Both preexisting immunity to influenza and age have been shown to be a correlate of influenza vaccine 25 response. Frailty, an indicator of functional impairment in older adults, has also been shown in one 26 study to predict lower influenza vaccine responses among non-veterans. In the current study we aimed 27 to determine the association between frailty, preexisting immunity and immune response to influenza 28 vaccine in older veterans. We analyzed 117 subjects (age range 62-95 years; median 81) divided into 3 29
Introduction 47
Seasonal Influenza has a disproportionately greater adverse effect on older adults. While persons over 48 the age of 65 comprise roughly 13% of the US population, the overwhelming majority of influenza 49 related deaths and most hospitalizations occur in this population [1] [2] [3] [4] . This pattern is even more 50 pronounced among those at the older extreme of this group [2] . Age-associated impaired cell-mediated 51 immunity renders aging older adults increasingly susceptible to infections while, at the same time, 52 resulting in reduced immune responses to vaccinations, the very strategy used to prevent infections [5-53 7] . Influenza has served as a prime example of this paradigm [8] . While influenza vaccine can reduce 54 complications such as pneumonia and hospitalizations among older adults [9, 10] , the magnitude of 55 mortality and morbidity benefit, among the elderly compared to younger adults has been a source of 56 debate [11, 12] . 57
This discrepancy in evidence highlights the heterogeneous nature of this population. One 58 source of variability is preexisting immunity to influenza. In fact, preexisting immunity to influenza 59 has been proposed as a greater correlate of immunity to influenza than age in the elderly [13] . Another 60 potential source of variable response to influenza vaccine is functional decline or frailty. Frailty 61 syndrome, an indicator of functional impairment in older adults, is a strong marker of increased risk for 62 poor health outcomes including falls, disability and death [14] . There has been increasing evidence to 63 suggest that frailty also negatively impacts the immune system, beyond what would be expected as a 64 result of aging. Existence of a dysregulated immune system, marked by a heightened inflammatory 65 state and increase in immunologic markers of T cell senescence, has been identified and described in 66 frail older adults [15] . B lymphocyte diversity has also been shown to decline in frail individuals, 67 making them more susceptible to novel antigens both via natural infection or immunization [16] . 68
Frailty has also been shown to have an impact on the innate immune system. Decreased production of 69 on October 20, 2017 by guest http://cvi.asm.org/
Downloaded from
Toll-like receptor ligand (TLR)-induced interleukin (IL)-12p70 and IL-23, cytokines that play an 70 important role in the protection against pathogens has been associated with frailty rather than age [17] . 71
There are some data to suggest that frailty may adversely affect responses to influenza and 72 pneumococcal vaccinations [18] [19] [20] . Further studies are needed to better understand the immune 73 response to influenza and vaccination, particularly among the frail elderly. 74
In this present study, we sought to determine the relationship between frailty and strain specific 75 influenza hemagglutination inhibition (HI) and microneutralization (MN) assays among older veterans. 76
These results may help identify those older adults who are most likely to have decreased response to 77 influenza vaccination and, as a result, persisting risk for morbidity and mortality from influenza despite 78
vaccination. 79

Methods and materials 80
Setting, sample, and study design: 81 This is an observational study in which Veterans 60 years of age or older, receiving care at the Louis 82
Stokes Cleveland VA Medical Center (LSCVAMC) outpatient geriatrics and internal medicine clinics 83 were enrolled over two influenza seasons. Those receiving immunosuppressive medications or with 84 immunosuppressive conditions including HIV, cancer undergoing chemotherapy, and severe anemia 85 were excluded from the study. Subjects in whom influenza vaccine was contraindicated due to allergy 86 to any component of the vaccine were also excluded. Subjects were recruited during the 2010-2011 87 Time activity questionnaire [23] . Grip strength was stratified by sex and body mass index, walking 105 speed was stratified by sex and height and physical activity score was stratified by sex as suggested by 106
Fried and colleagues. Subjects were assigned to the non-frail (NF) category for 0 criteria met, pre-frail 107 (PF) for 1-2 criteria and frail (F) for 3 or more criteria met on the Fried frailty instrument. Laboratory 108
measurements: 109
Hemagglutinin inhibition (HI) and microneutralization assays are measured for influenza B, 110 A(H1N1)pdm09 and A(H3N2) viruses. HI and microneutralization titers were performed using routine 111 methods as previously described [24] [25] [26] [27] 
Statistical analysis: 119
Analysis was completed in SPSS; Graphpad Prism 6.0 and R 3.2.2 using the ggplot2 package to 120 graphically represent the data. Differences in geometric mean titers (GMT) ratios (pre to post HI or 121 microneutralization titers) among frailty groups were calculated using ANOVA. For pre-to post-122 vaccination titer comparisons, log 2 -transformed HI and microneutralization pre and post titers were 123 used as independent and dependent variables respectively. Associations between age and fold increases 124 in titers were examined using Spearman Rank correlations both overall and within frailty groups. 125
Results 126
We classified 117 subjects according to the three Fried Frailty Phenotype categories: non-frail (N=23), 127 pre-frail (N=50) and frail (N=44). Prevalence of frailty in this cohort was 43% while pre-frailty was 128 identified in 38% of the subjects. The median age in the NF group (68 years, range 62-90) was 129 significantly lower than the PF (80 years; 62-92) and frail (82 years; 62-92) groups. As expected in an 130 older veteran population, the subjects were primarily male (96%). African Americans accounted for 131 over half (54%) of the study subjects. Pre-vaccination seroprotection rates were similar for all viruses 132 (B: 27%; H1N1: 24%, H3N2: 28%). After vaccination, seroprotection rates were significantly higher 133 for A(H3N2) (64%) compared with A(H1N1)pdm09 (50%) and B viruses (47%) (p=0.02). These rates 134 did not vary based on frailty status (data not shown). 87% of subjects had received the seasonal 135 influenza vaccine in the preceding year. viruses were similar among the three groups ( Figure 1A) . Microneutralization fold increases after 140 vaccine were also similar between frailty groups ( Figure 1B) . Additionally, while aging was generally 141 associated with lower immunity to influenza, these correlations were not statistically significant when 142 evaluated separately within frailty groups (data not shown). On the other hand, pre-existing immunity 143 to influenza was found to strongly correlated post-vaccination titer (Figure 2 Figure 2B ). 152
Discussion: 153
In the present study we investigated relationships between frailty status and influenza vaccine 154 responses in older veterans with a secondary aim of examining the role of preexisting immunity in 155 older adults. Seroprotection rates were higher for A(H3N2) than A(H1N1)pdm09 or B viruses. In our 156 cohort, HI or microneutralization fold increases did not differ by frailty status. When assessed within 157 frailty groups, increased age was not significantly associated with lower influenza vaccine responses. 158
Pre-vaccination strain specific immunity was found to be strongly associated with post-vaccine 159 responses in all frailty groups with the greatest correlations in microneutralization titers observed in the 160 non-frail group. 161 on October 20, 2017 by guest http://cvi.asm.org/
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Overall seroprotection rates were lower for A(H1N1)pdm09 and B viruses than for A(H3N2). 162
These rates did not differ by frailty status. Our observed rates of seroprotection were similar to what 163 has been reported among older adults, including higher immune protection against A(H3N2) [13] . 164
Incidentally, among older adults, A(H3N2) virus has been found to be associated with more severe 165 morbidity and increased mortality than A(H1N1)pdm09 [2, 3] . Notably, there were similar levels of 
Pre-existing immunity was a strong correlate of post-vaccine immunity in our cohort. This is 207 consistent with a previously published report by Reber and colleagues in which pre-vaccination titers 208
were the best predictor of post-vaccination immunity to influenza in adults older than 50 years of age 209
[13]. In fact, they found age to be only modestly associated with lower vaccine responses. We also did 210 not find age to be a significant negative factor when evaluated within the frailty groups. 
